IGF-1 LR3 (Receptor Grade) 1mg

$250.00

PRODUCT SHORT DESCRIPTION

IGF-1 LR3 (Receptor Grade) 1mg is a premium, high-potency synthetic 83-amino-acid analog of human Insulin-like Growth Factor-1. Featuring an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, this 1000mcg configuration is engineered strictly for investigating sustained somatotropic signaling and uninhibited receptor binding kinetics.

Description

Introduction to IGF-1 LR3 (Receptor Grade) 1mg

IGF-1 LR3, biochemically designated as Long Arg3 Insulin-like Growth Factor-1, is a highly advanced, synthetic structural analog of endogenous human IGF-1 engineered for high-resolution investigations into cellular proliferation, metabolic signaling, and tissue hypertrophy. While native IGF-1 consists of a 70-amino-acid chain, the LR3 modification extends the sequence into an 83-amino-acid single-chain polypeptide. This modification incorporates a 13-amino-acid extension at the N-terminus alongside a strategic substitution of an Arginine for the native Glutamic Acid at position 3 ($\text{Glu}^3 \rightarrow \text{Arg}^3$). At USA PEPTIDE SCIENCES, we provide this premium analog in a highly stable, 1mg (Receptor Grade) lyophilized matrix. This format offers molecular biology, endocrinology, and regenerative medicine laboratories an optimized research probe designed to evaluate prolonged anabolic signaling free from the buffering interference of domestic binding matrices.

Research Overview: Extended Half-Life and IGFBP Evasion

The primary scientific value of Receptor Grade IGF-1 LR3 1mg centers on its heavily altered structural pharmacokinetics. In baseline biological systems, free IGF-1 is rapidly sequestered by a group of six specific Insulin-like Growth Factor-Binding Proteins (IGFBPs), which regulate receptor interaction and restrict the peptide’s biological half-life to approximately 10 to 20 minutes.

Key areas of active scientific investigation utilizing IGF-1 LR3 1mg include:

  • IGFBP Binding Inhibition: Modeling the steric hindrance introduced by the 13-amino-acid N-terminal extension and the $\text{Arg}^3$ substitution. This precise structural layout reduces the peptide’s affinity for inhibitory binding proteins by over 1,000-fold, allowing the analog to remain predominantly in its free, active state within culture media.

  • Sustained Receptor-Ligand Kinetics: Investigating the prolonged activation window of the type 1 IGF Receptor (IGF-1R). Because it evades circulating binding proteins, IGF-1 LR3 exhibits an extended biological half-life estimated between 15 and 20 hours, facilitating long-term longitudinal data capture.

  • Intracellular Hypertrophy Pathways: Tracking downstream transcriptomic signaling cascades following sustained receptor engagement, specifically mapping the upregulation of the PI3K/Akt/mTOR pathway that drives protein synthesis and cellular replication.

  • Myoblast Proliferation and Differentiation: Analyzing the capacity of the analog to stimulate satellite cell activation, support muscle cell division, and guide the structural fusion of myoblasts into mature multinucleated myotubes in vitro.

Quality Standards & Analytical Testing

At USA PEPTIDE SCIENCES, maintaining absolute data integrity and compound reproducibility is the foundation of our manufacturing operations. Every single production lot of IGF-1 LR3 (Receptor Grade) 1mg undergoes a rigid multi-tier quality control validation protocol to eliminate compounding variables and experimental artifacts. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater. This severe analytical testing verifies the precise 83-amino-acid sequence map, correct disulfide bridge configuration, and exact molecular weight while ensuring the total absence of residual synthesis reagents, truncated fragments, or raw contaminants. A batch-specific Certificate of Analysis (COA) accompanies every order to guarantee absolute reproducibility.

Storage and Handling Requirements

To preserve the complex tertiary structure and prevent denaturation of IGF-1 LR3 1mg, the vacuum-sealed, lyophilized powder must be stored long-term in a freezer environment at -20°C. Prior to introducing the compound into your laboratory workflow, reconstitution must be carried out using an appropriate sterile, non-pyrogenic, or slightly acidic solution (such as diluted acetic acid or sterile water) optimized for complex polypeptide stability. Once transitioned into a liquid state, the growth factor is highly sensitive to thermal breakdown and mechanical shear stress; reconstituted vials must be maintained under constant refrigeration at 2°C to 8°C. Researchers must dissolve the compound via a slow, gentle swirling motion, avoiding any aggressive mechanical agitation, inversion, or shaking.

Research Use Disclaimer

The compounds distributed by USA PEPTIDE SCIENCES, including IGF-1 LR3 (Receptor Grade) 1mg, are designated strictly for laboratory research purposes only. Under no circumstances are these products approved or intended for human or veterinary consumption, direct clinical diagnostics, or therapeutic drug administration. All handling, measuring, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.

Reviews (0)
0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “IGF-1 LR3 (Receptor Grade) 1mg”

Your email address will not be published. Required fields are marked *